Melodiol Global Health (AU:ME1) has released an update.
Melodiol Global Health Limited has announced the issuance of new fully paid ordinary shares, in compliance with the Australian Corporations Act, without the need for a disclosure document. The Australia-based company, which specializes in plant-based therapeutic and lifestyle products, emphasizes that all necessary legal provisions have been met and there are no undisclosed material facts that would be expected in a disclosure document. Investors are given assurance of the company’s adherence to the regulatory standards.
For further insights into AU:ME1 stock, check out TipRanks’ Stock Analysis page.
